Applications of Nanotechnology in Veterinary Drug Delivery

Dear Colleagues,

The rapid advancement of nanotechnology in recent years has significantly impacted various fields within life sciences. Given that some of these emerging technologies have potential applications in veterinary medicine, this Special Issue aims at fostering innovation in the field through the use of nanotechnology.

Nanotechnology offers promising solutions for overcoming key challenges in veterinary pharmacology, such as improving drug bioavailability, enabling targeted and controlled drug release, and minimizing side effects. Additionally, nanocarriers can enhance the solubility of poorly water-soluble drugs, ensuring more effective treatments across different species. Research on novel nano-based delivery systems, including liposomes, polymeric nanoparticles, and lipid-based carriers, is essential for advancing veterinary therapeutics.

As veterinary nanotechnology is still in its early stages, we encourage the submission of research on the synthesis, characterization, and application of nanotechnology-based drugs in veterinary medicine, while also emphasizing studies on safety, toxicity, environmental impact, cost-effective production, large-scale manufacturing, and regulatory considerations, all from a One Health perspective.

Dr. Constantin Cerbu
Prof. Dr. Ildikó Bácskay
Dr. Carla Martins Lopes
Guest Editors

Dr. Emilia Trif
Guest Editor Assistant

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.